eCysticFibrosis Review

eCysticFibrosis Review


No-cost CME from Johns Hopkins


Free

4.2for iPhone, iPad and more
9.9
1 Ratings
DKBmed LLC
Developer
31.7 MB
Size
May 13, 2020
Update Date
Medical
Category
17+
Age Rating
Age Rating
4+
Apps in this category do not contain restricted content.
9+
Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.
12+
Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.
17+
You must be at least 17 years old to access this App.
Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.
eCysticFibrosis Review Screenshots
eCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review poster
eCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review postereCysticFibrosis Review poster

About eCysticFibrosis Review

eCysticFibrosis Review is a no-cost CME program developed by Johns Hopkins University School of Medicine (JHUSOM) in partnership with DKBmed. Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature with accompanying podcasts to illustrate how to apply that information in the clinic.

eCysticFibrosis Review is part of the highly successful eLiterature Review series. Over 50,000 health care providers are subscribed to eLiterature Review in areas such as viral hepatitis, primary care, pulmonology, HIV, multiple sclerosis, and diabetes. Join your colleagues in this highly-rated educational program.

eCysticFibrosis Review Volume 9 covers key topics such as:
-How to screen and have conversations with your patients about their mental health.
-What you should know about the recently approved triple combination modulator.
-Expert analysis of the current trial data for long-term CFTR therapy

It is practically impossible for time-pressed clinicians to stay current with new clinical developments by reading medical literature alone, despite the value of doing so. To address this, the Johns Hopkins University School of Medicine (JHUSOM), in partnership with DKBmed, has enhanced the way clinicians receive this vital information through our highly successful eLiterature Review series, spanning a variety of disease states and covering a wide range of clinical expertise. The nuances of each disease require a tailored approach to facilitate optimal learning techniques and knowledge retention. In previous eLiterature Review, some programs have been specifically directed to the specialist practitioner (eg, eOphthalmology, eNeonatalogy), but the majority have targeted a combination of both specialists and primary care clinicians that treat patients with chronic disease (eg, eDiabetes, eViralHepatitis).

What clinicians are saying about eCysticFibrosis Review:
“You guys saved my day!”

“I’m always having trouble keeping up with literature – this makes it so much easier!”

“I very much enjoyed the synopses of the studies with the questions after. They really helped me learn the material!”
Show More

What's New in the Latest Version 4.2

Last updated on May 13, 2020
Old Versions
A new volume of eCysticFibrosis Review just launched! This new volume will continues our focus on helping you improve the health and quality of life of your patients through best-practice treatment. Volume 9 covers:
-Mental health: how to recognize and address mental health issues in patients with CF and their care team
-CFTR Modulators: updates on the recently approved triple combination modulator therapy.
-Expert analysis of the current trial data for long-term CFTR therapy.
-Antibiotic treatment: how do multidrug resistance and CFTR therapy affect antibiotic treatment.

-Bug fixes
Show More
Version History
4.2
May 13, 2020
A new volume of eCysticFibrosis Review just launched! This new volume will continues our focus on helping you improve the health and quality of life of your patients through best-practice treatment. Volume 9 covers:
-Mental health: how to recognize and address mental health issues in patients with CF and their care team
-CFTR Modulators: updates on the recently approved triple combination modulator therapy.
-Expert analysis of the current trial data for long-term CFTR therapy.
-Antibiotic treatment: how do multidrug resistance and CFTR therapy affect antibiotic treatment.

-Bug fixes
4.1
Mar 28, 2020
few bugs fixed
4.0
Feb 13, 2020
-Performance enhancements
-Design and user interface improvements
-Bug fixes
3.3
Aug 16, 2017
Updated copy
3.2
Feb 6, 2017
Updated copy
3.1
Jan 29, 2017
Updated user experience.
3.0.1
Jul 12, 2016
updated icons.
3.0.0
Feb 1, 2016
New user interface
2.3.0
Mar 4, 2015
New user interface and other features.
1.0.0
Oct 14, 2013

eCysticFibrosis Review FAQ

Click here to learn how to download eCysticFibrosis Review in restricted country or region.
Check the following list to see the minimum requirements of eCysticFibrosis Review.
iPhone
Requires iOS 10.0 or later.
iPad
Requires iPadOS 10.0 or later.
iPod touch
Requires iOS 10.0 or later.
eCysticFibrosis Review supports English

eCysticFibrosis Review Alternative

You May Also Like

Get more from DKBmed LLC